Cite

HARVARD Citation

    Vivanet, G. et al. (2022). Ten years-experience of sunitinib in the treatment of advanced pan-NETs: an update on safety profile. Expert opinion on drug safety. 21 (3), pp. 303-310. [Online]. 
  
Back to record